Related Experiment Video
Updated: Sep 13, 2025
Tracking the Mammary Architectural Features and Detecting Breast Cancer with Magnetic Resonance Diffusion Tensor Imaging
Published on: December 15, 2014
A Scoring System Based on Diffusion Tensor Imaging and Blood Biochemistry Tests for Diagnosing Biliary Atresia in
Bo Liu1, Xiaoying Ni2, Jin Zhu3
1Chongqing Key Laboratory of Pediatric Metabolism and Inflammatory Diseases, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders, Department of Radiology, Children's Hospital of Chongqing Medical University, Chongqing 400014, China.
This study developed a noninvasive scoring system using diffusion tensor imaging (DTI) and blood tests to diagnose biliary atresia (BA) in infants. The system showed high accuracy and sensitivity, offering a potential new diagnostic method.
Area of Science:
- Medical Imaging
- Biochemistry
- Pediatric Gastroenterology
Background:
- Biliary atresia (BA) is a serious neonatal liver disease requiring early diagnosis.
- Current diagnostic methods can be invasive or have limitations.
- Diffusion tensor imaging (DTI) and blood biochemistry offer potential noninvasive markers.
Purpose of the Study:
- To evaluate the diagnostic value of a scoring system combining DTI and blood biochemistry for BA in infants.
- To develop and validate a predictive model for BA diagnosis.
Main Methods:
- A scoring system was developed using binary logistic regression on DTI parameters (hepatic lobe apparent diffusion coefficient) and serum gamma-glutamyl transpeptidase levels.
- The system was trained on 51 infants (36 BA, 15 non-BA) and validated on 23 infants (14 BA, 9 non-BA).
- Diagnostic performance was assessed using receiver operating characteristic (ROC) curve analysis.
Main Results:
- The scoring system incorporated mean apparent diffusion coefficient values of hepatic right and caudate lobes and serum gamma-glutamyl transpeptidase.
- In the validation cohort, the system achieved 95.65% accuracy, 100% sensitivity, and 88.89% specificity for BA.
- Area under the ROC curve was 0.87 in the training cohort and 0.94 in the validation cohort (p ≤ 0.001).
Conclusions:
- A noninvasive scoring system integrating DTI and blood biochemistry demonstrates strong diagnostic performance for biliary atresia in infants.
- This scoring system shows potential as a valuable tool for differentiating BA, aiding in early diagnosis and management.
- Further validation in larger cohorts may establish this as a standard noninvasive diagnostic approach.
